Home > Healthcare > Medical Devices > Diagnostic Devices > Tissue Diagnostics Market

Tissue Diagnostics Market Size

Report ID: GMI3754
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Tissue Diagnostics Market Size

Tissue Diagnostics Market size was valued at over USD 5 billion in 2022 and is projected to reach more than USD 11 billion by 2032.

To get key market trends

Download Free Sample

Tissue diagnostics, also known as histopathology or surgical pathology, is a branch of medicine that involves the examination and analysis of tissue samples obtained from patients. It is a crucial aspect of diagnosing various diseases, including cancer and other disorders. Rising healthcare expenditure and growing awareness regarding cancer and other disorders has stimulated the demand for tissue diagnostic.

Tissue Diagnostics Market Report Attributes
Report Attribute	Details
Base Year:	2022
Tissue Diagnostics Market Size in 2022:	USD 5.1 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	8.1%
2032 Value Projection:	USD 11.1 Billion
Historical Data for:	2018 to 2022
No. of Pages:	210
Tables, Charts & Figures:	490
Segments covered:	Product, Technology, Application, End-use, and Region
Growth Drivers:	Rising prevalence of cancer globally Growth of personalized therapeutics and diagnostics Growing demand for digital pathology Increasing number of private diagnostic centres globally
Pitfalls & Challenges:	Lack of skilled professionals High Cost of diagnosis and reimbursement issues

Learn more about the key segments shaping this market

Download Free Sample

In developing countries, there has been a rising need for private diagnostic laboratories because of low level of service available from the public sector. For instance, in South Africa, there is a mix of public and private laboratories. However, major provider of diagnostic services is National Health Laboratory Service (NHLS) with a nationwide network of over 265 pathology laboratories. The growing awareness about disease diagnosis and prevention has accelerated demand for disease detection tests, thus positively impacting market growth.

Authors: Mariam Faizullabhoy , Subodh Kharad

Frequently Asked Questions (FAQ) :

Global tissue diagnostics industry size was over USD 5 billion in 2022 and will reach more than USD 11 billion by 2032.

The digital pathology technology segment will witness a 8.6% CAGR between 2023 to 2032 due to an in the adoption of whole-slide imaging (WSI) by pathologists.

U.S. tissue diagnostics market will be valued at more than USD 3 billion by 2032 as to high incidence rate of cancer.

F. Hoffmann-La Roche Ltd., Siemens, Danaher, bioMérieux SA, Abbott Laboratories, QIAGEN, Becton Dickinson & Company, Thermo Fisher Scientific, Inc., Merck KGaA, Agilent Technologies, Inc, GE Healthcare, BioGenex, and Cell Signaling Technology, Inc.